User login
Pediatric Dermatology: Summer 2017
An editorial supplement to Pediatric News and Dermatology News
Articles include:
- Pivotal dupilumab results for eczema create a sensation
- Fight back against psoriasis bullies
- Monthly lab testing for isotretinoin? No need
- Consider all acne in Latinos inflammatory
- Commentaries from Lawrence F. Eichenfield, MD & Robert Sidbury, MD, MPH
- And more …
Faculty:
Lawrence F. Eichenfield, M.D.
Dr. Eichenfield is in the division of pediatric and adolescent dermatology at Rady Children’s Hospital–San Diego, and the University of California, San Diego. Relative to the commentaries, Dr. Eichenfield disclosed he has served as a consultant for Pfizer.
Robert Sidbury, MD, MPH
Dr. Sidbury is chief of dermatology at Seattle Children’s Hospital and professor, department of pediatrics, University of Washington, Seattle. Relative to the commentaries, Dr. Sidbury disclosed he has served as site primary investigator on phase III trials of crisaborole.
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
An editorial supplement to Pediatric News and Dermatology News
Articles include:
- Pivotal dupilumab results for eczema create a sensation
- Fight back against psoriasis bullies
- Monthly lab testing for isotretinoin? No need
- Consider all acne in Latinos inflammatory
- Commentaries from Lawrence F. Eichenfield, MD & Robert Sidbury, MD, MPH
- And more …
Faculty:
Lawrence F. Eichenfield, M.D.
Dr. Eichenfield is in the division of pediatric and adolescent dermatology at Rady Children’s Hospital–San Diego, and the University of California, San Diego. Relative to the commentaries, Dr. Eichenfield disclosed he has served as a consultant for Pfizer.
Robert Sidbury, MD, MPH
Dr. Sidbury is chief of dermatology at Seattle Children’s Hospital and professor, department of pediatrics, University of Washington, Seattle. Relative to the commentaries, Dr. Sidbury disclosed he has served as site primary investigator on phase III trials of crisaborole.
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
An editorial supplement to Pediatric News and Dermatology News
Articles include:
- Pivotal dupilumab results for eczema create a sensation
- Fight back against psoriasis bullies
- Monthly lab testing for isotretinoin? No need
- Consider all acne in Latinos inflammatory
- Commentaries from Lawrence F. Eichenfield, MD & Robert Sidbury, MD, MPH
- And more …
Faculty:
Lawrence F. Eichenfield, M.D.
Dr. Eichenfield is in the division of pediatric and adolescent dermatology at Rady Children’s Hospital–San Diego, and the University of California, San Diego. Relative to the commentaries, Dr. Eichenfield disclosed he has served as a consultant for Pfizer.
Robert Sidbury, MD, MPH
Dr. Sidbury is chief of dermatology at Seattle Children’s Hospital and professor, department of pediatrics, University of Washington, Seattle. Relative to the commentaries, Dr. Sidbury disclosed he has served as site primary investigator on phase III trials of crisaborole.
©Copyright 2017, by Frontline Medical Communications Inc. All rights reserved.
Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer
This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.
Click here to read the supplement
Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska
Kevin R. Murphy, MD
Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska
This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.
Click here to read the supplement
Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska
Kevin R. Murphy, MD
Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska
This newsletter, Practical Considerations for Moderate to Severe Asthma, Part 1: Management, Biomarkers, and When to Refer, provides detailed guidance for nurse practitioners and physician assistants on how to identify, evaluate, and treat patients with poorly controlled, moderate to severe asthma.
Click here to read the supplement
Clinical Research Coordinator
Boys Town National Research Hospital
Boys Town, Nebraska
Kevin R. Murphy, MD
Director of Allergy, Asthma, and Pulmonary Research
Boys Town National Research Hospital
Boys Town, Nebraska
Department of Pediatrics
University of Nebraska Medical Center
Creighton University School of Medicine
Omaha, Nebraska
Highlights from The 2017 Society of Gynecologic Surgeons Scientific Meeting
PART 1
Robert E. Gutman, MD
FPMRS Program Director
MedStar Washington Hospital Center
Associate Professor
Departments of Urology and Obstetrics/Gynecology
Georgetown University
Washington, DC
Elizabeth R. Mueller, MD, MSME
Professor, Departments of Urology and Obstetrics/Gynecology
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center
Maywood, Illinois
Janet Bickel, MA
Leadership and Career Development Coach
Falls Church, Virginia
Kristin M. Jacobs, MD
Steering Committee Chair, AUGS-SGS Group of FPRN®
FPMRS Fellow, Division of Urogynecology and Reconstructive Pelvic Surgery
Brown University
Providence, Rhode Island
Lior Lowenstein, MD, MS, MHA
Clinical Associate Professor, Department of Obstetrics and Gynecology
Rambam Health Center Campus, Ruth and Bruce Rappaport Faculty of Medicine
Technion Israel Institute of Technology
Haifa, Israel
Drs. Gutman, Jacobs, and Lowenstein and Ms. Bickel report no financial relationships relevant to their articles. Dr. Mueller reports that she is an investigator for and is on the advisory board of Astellas Medical and Scientific Affairs.
PART 2
Geoffrey W. Cundiff, MD
Dr. Victor Gomel Professor and Head
Department of Obstetrics and Gynaecology
University of Bristish Columbia
Vancouver, British Columbia
Kimberly Kenton, MD, MS
Professor, Obstetrics and Gynaecology and Urology
Divison Chief and Fellowship Program Director
Female Pelvis Medicine and Reconstructive Surgery
Medicial Director, Women's Integrated Pelvic Health Program
Northwestern Medicine/Northwestern University Feinberg School of Medicince
Chicago, Illinois
Denise M. Elser, MD
Urogynecologist
Women's Health Institute of Illinois
Oak Lawn, Illinois
Drs. Cundiff and Elser report no financial relationships relevant to their articles. Dr. Kenton reports that she receives grant or research support from Boston Scientific and the National Institutes of Health, and that she serves as an expert witness for the Butler Snow Law Firm/Ethicon.
PART 1
Robert E. Gutman, MD
FPMRS Program Director
MedStar Washington Hospital Center
Associate Professor
Departments of Urology and Obstetrics/Gynecology
Georgetown University
Washington, DC
Elizabeth R. Mueller, MD, MSME
Professor, Departments of Urology and Obstetrics/Gynecology
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center
Maywood, Illinois
Janet Bickel, MA
Leadership and Career Development Coach
Falls Church, Virginia
Kristin M. Jacobs, MD
Steering Committee Chair, AUGS-SGS Group of FPRN®
FPMRS Fellow, Division of Urogynecology and Reconstructive Pelvic Surgery
Brown University
Providence, Rhode Island
Lior Lowenstein, MD, MS, MHA
Clinical Associate Professor, Department of Obstetrics and Gynecology
Rambam Health Center Campus, Ruth and Bruce Rappaport Faculty of Medicine
Technion Israel Institute of Technology
Haifa, Israel
Drs. Gutman, Jacobs, and Lowenstein and Ms. Bickel report no financial relationships relevant to their articles. Dr. Mueller reports that she is an investigator for and is on the advisory board of Astellas Medical and Scientific Affairs.
PART 2
Geoffrey W. Cundiff, MD
Dr. Victor Gomel Professor and Head
Department of Obstetrics and Gynaecology
University of Bristish Columbia
Vancouver, British Columbia
Kimberly Kenton, MD, MS
Professor, Obstetrics and Gynaecology and Urology
Divison Chief and Fellowship Program Director
Female Pelvis Medicine and Reconstructive Surgery
Medicial Director, Women's Integrated Pelvic Health Program
Northwestern Medicine/Northwestern University Feinberg School of Medicince
Chicago, Illinois
Denise M. Elser, MD
Urogynecologist
Women's Health Institute of Illinois
Oak Lawn, Illinois
Drs. Cundiff and Elser report no financial relationships relevant to their articles. Dr. Kenton reports that she receives grant or research support from Boston Scientific and the National Institutes of Health, and that she serves as an expert witness for the Butler Snow Law Firm/Ethicon.
PART 1
Robert E. Gutman, MD
FPMRS Program Director
MedStar Washington Hospital Center
Associate Professor
Departments of Urology and Obstetrics/Gynecology
Georgetown University
Washington, DC
Elizabeth R. Mueller, MD, MSME
Professor, Departments of Urology and Obstetrics/Gynecology
Loyola University Chicago Stritch School of Medicine
Loyola University Medical Center
Maywood, Illinois
Janet Bickel, MA
Leadership and Career Development Coach
Falls Church, Virginia
Kristin M. Jacobs, MD
Steering Committee Chair, AUGS-SGS Group of FPRN®
FPMRS Fellow, Division of Urogynecology and Reconstructive Pelvic Surgery
Brown University
Providence, Rhode Island
Lior Lowenstein, MD, MS, MHA
Clinical Associate Professor, Department of Obstetrics and Gynecology
Rambam Health Center Campus, Ruth and Bruce Rappaport Faculty of Medicine
Technion Israel Institute of Technology
Haifa, Israel
Drs. Gutman, Jacobs, and Lowenstein and Ms. Bickel report no financial relationships relevant to their articles. Dr. Mueller reports that she is an investigator for and is on the advisory board of Astellas Medical and Scientific Affairs.
PART 2
Geoffrey W. Cundiff, MD
Dr. Victor Gomel Professor and Head
Department of Obstetrics and Gynaecology
University of Bristish Columbia
Vancouver, British Columbia
Kimberly Kenton, MD, MS
Professor, Obstetrics and Gynaecology and Urology
Divison Chief and Fellowship Program Director
Female Pelvis Medicine and Reconstructive Surgery
Medicial Director, Women's Integrated Pelvic Health Program
Northwestern Medicine/Northwestern University Feinberg School of Medicince
Chicago, Illinois
Denise M. Elser, MD
Urogynecologist
Women's Health Institute of Illinois
Oak Lawn, Illinois
Drs. Cundiff and Elser report no financial relationships relevant to their articles. Dr. Kenton reports that she receives grant or research support from Boston Scientific and the National Institutes of Health, and that she serves as an expert witness for the Butler Snow Law Firm/Ethicon.
Mild Persistent Asthma: Characteristics, Treatment, and Unmet Needs
This newsletter, Mild Persistent Asthma: Characteristics, Treatment, and Unmet Needs, discusses the characteristics and burden of mild persistent asthma and provides practical information on its diagnosis and appropriate management.
Click here to read the supplement
PA-C
Former American Academy of Physician Assistants (AAPA) Liaison to the American Academy of Allergy Asthma and Immunology (AAAAI) and former Liaison from AAAAI to the AAPA.
This newsletter, Mild Persistent Asthma: Characteristics, Treatment, and Unmet Needs, discusses the characteristics and burden of mild persistent asthma and provides practical information on its diagnosis and appropriate management.
Click here to read the supplement
PA-C
Former American Academy of Physician Assistants (AAPA) Liaison to the American Academy of Allergy Asthma and Immunology (AAAAI) and former Liaison from AAAAI to the AAPA.
This newsletter, Mild Persistent Asthma: Characteristics, Treatment, and Unmet Needs, discusses the characteristics and burden of mild persistent asthma and provides practical information on its diagnosis and appropriate management.
Click here to read the supplement
PA-C
Former American Academy of Physician Assistants (AAPA) Liaison to the American Academy of Allergy Asthma and Immunology (AAAAI) and former Liaison from AAAAI to the AAPA.
Highlights From the 69th Annual Meeting of the American Academy of Neurology
Selected highlights from the 69th Annual Meeting of the American Academy of Neurology
Selected highlights from the 69th Annual Meeting of the American Academy of Neurology
Selected highlights from the 69th Annual Meeting of the American Academy of Neurology
The role of moisturizers and lubricants in genitourinary syndrome of menopause and beyond
Michael L. Krychman, MD
Executive Director, Southern California Center for Sexual Health and Survivorship Medicine
Newport Beach, California
Alyssa Dweck, MD
CareMount Medical, PC, Mt. Kisco, New York
Assistant Clinical Professor, Department of Obstetrics, Gynecology, and Reproductive Science
Mount Sinai School of Medicine, New York, New York
Consultant, Massachusetts General Hospital, Vincents Memorial Ob/Gyn Service
Boston, Massachusetts
Sheryl Kingsberg, PhD
Chief, Division of Behavioral Medicine, Department of Obstetrics & Gynecology
University Hospitals, Cleveland Medical Center
Professor, Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio
Lisa Larkin, MD
President, Lisa Larkin, MD, & Associates
Cincinnati, Ohio
Dr. Krychman reports receiving research support from New England Research Institutes (NERI) and being a consultant for Palatin, Shionogi, Inc, Sylk USA, TherapeuticsMD, and Valeant Pharmaceuticals; a speaker for Shionogi and Valeant; and an advisor for Uniderm.
Dr. Dweck reports being a consultant to Uniderm and a speaker for Bayer Pharmaceuticals.
Dr. Kingsberg reports receiving grant or research support from Palatin; being a consultant to Acerus, AMAG, Emotional Brain, EndoCeutics, Materna, NovoNordisk, Nuelle, Palatin, Pfizer, Scientific Strategic Solutions, Shionogi, TherapeticsMD, and Valeant Pharmaceuticals; and being a speaker for Valeant.
Dr. Larkin reports being a consultant and speaker for Valeant Pharmaceuticals.
OBG Management and the roundtable faculty do not endorse any specific product mentioned over another in this roundtable discussion.
Michael L. Krychman, MD
Executive Director, Southern California Center for Sexual Health and Survivorship Medicine
Newport Beach, California
Alyssa Dweck, MD
CareMount Medical, PC, Mt. Kisco, New York
Assistant Clinical Professor, Department of Obstetrics, Gynecology, and Reproductive Science
Mount Sinai School of Medicine, New York, New York
Consultant, Massachusetts General Hospital, Vincents Memorial Ob/Gyn Service
Boston, Massachusetts
Sheryl Kingsberg, PhD
Chief, Division of Behavioral Medicine, Department of Obstetrics & Gynecology
University Hospitals, Cleveland Medical Center
Professor, Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio
Lisa Larkin, MD
President, Lisa Larkin, MD, & Associates
Cincinnati, Ohio
Dr. Krychman reports receiving research support from New England Research Institutes (NERI) and being a consultant for Palatin, Shionogi, Inc, Sylk USA, TherapeuticsMD, and Valeant Pharmaceuticals; a speaker for Shionogi and Valeant; and an advisor for Uniderm.
Dr. Dweck reports being a consultant to Uniderm and a speaker for Bayer Pharmaceuticals.
Dr. Kingsberg reports receiving grant or research support from Palatin; being a consultant to Acerus, AMAG, Emotional Brain, EndoCeutics, Materna, NovoNordisk, Nuelle, Palatin, Pfizer, Scientific Strategic Solutions, Shionogi, TherapeticsMD, and Valeant Pharmaceuticals; and being a speaker for Valeant.
Dr. Larkin reports being a consultant and speaker for Valeant Pharmaceuticals.
OBG Management and the roundtable faculty do not endorse any specific product mentioned over another in this roundtable discussion.
Michael L. Krychman, MD
Executive Director, Southern California Center for Sexual Health and Survivorship Medicine
Newport Beach, California
Alyssa Dweck, MD
CareMount Medical, PC, Mt. Kisco, New York
Assistant Clinical Professor, Department of Obstetrics, Gynecology, and Reproductive Science
Mount Sinai School of Medicine, New York, New York
Consultant, Massachusetts General Hospital, Vincents Memorial Ob/Gyn Service
Boston, Massachusetts
Sheryl Kingsberg, PhD
Chief, Division of Behavioral Medicine, Department of Obstetrics & Gynecology
University Hospitals, Cleveland Medical Center
Professor, Reproductive Biology and Psychiatry
Case Western Reserve University School of Medicine
Cleveland, Ohio
Lisa Larkin, MD
President, Lisa Larkin, MD, & Associates
Cincinnati, Ohio
Dr. Krychman reports receiving research support from New England Research Institutes (NERI) and being a consultant for Palatin, Shionogi, Inc, Sylk USA, TherapeuticsMD, and Valeant Pharmaceuticals; a speaker for Shionogi and Valeant; and an advisor for Uniderm.
Dr. Dweck reports being a consultant to Uniderm and a speaker for Bayer Pharmaceuticals.
Dr. Kingsberg reports receiving grant or research support from Palatin; being a consultant to Acerus, AMAG, Emotional Brain, EndoCeutics, Materna, NovoNordisk, Nuelle, Palatin, Pfizer, Scientific Strategic Solutions, Shionogi, TherapeticsMD, and Valeant Pharmaceuticals; and being a speaker for Valeant.
Dr. Larkin reports being a consultant and speaker for Valeant Pharmaceuticals.
OBG Management and the roundtable faculty do not endorse any specific product mentioned over another in this roundtable discussion.
The Cardiovascular Safety of Nonsteroidal Anti-Inflammatory Drugs: Putting the Evidence in Perspective
Topics Include:
- Key Prospective Clinical Trials
- Danish Registry Study
- Meta-Analyses
- FDA Actions
- PRECISION Trial
Faculty/Faculty Disclosure:
Martin Quan, MD
Professor of Clinical Family Medicine
David Geffen School of Medicine at UCLA
Vice Chair for Academic Affairs
UCLA Department of Family Medicine
Los Angeles, CA
Dr. Quan discloses that he has no real or apparent conflicts to report.
Topics Include:
- Key Prospective Clinical Trials
- Danish Registry Study
- Meta-Analyses
- FDA Actions
- PRECISION Trial
Faculty/Faculty Disclosure:
Martin Quan, MD
Professor of Clinical Family Medicine
David Geffen School of Medicine at UCLA
Vice Chair for Academic Affairs
UCLA Department of Family Medicine
Los Angeles, CA
Dr. Quan discloses that he has no real or apparent conflicts to report.
Topics Include:
- Key Prospective Clinical Trials
- Danish Registry Study
- Meta-Analyses
- FDA Actions
- PRECISION Trial
Faculty/Faculty Disclosure:
Martin Quan, MD
Professor of Clinical Family Medicine
David Geffen School of Medicine at UCLA
Vice Chair for Academic Affairs
UCLA Department of Family Medicine
Los Angeles, CA
Dr. Quan discloses that he has no real or apparent conflicts to report.
Rare Neurological Disease Special Report
Click here to download the digital edition. 
Click here to download the digital edition.
Click here to download the digital edition.
Neuromyelitis Optica Spectrum Disorders: Critical Role of Complement-Dependent Cytotoxicity
Critical Role of Complement-Dependent Cytotoxicity
The complement system was once thought to have a fairly limited role in the immune system, recognizing and eliminating pathogens. Now, however, complement proteins are known to have a much broader role in immunity, and dysregulation of the complement system has been shown to affect the pathogenesis and clinical picture of several autoimmune diseases. This supplement discusses the role of complement-dependent cytotoxicity in the pathophysiology of neuromyelitis optica spectrum disorders.
Click here to read the supplement
US/UNB-NMO/17/0002c
The complement system was once thought to have a fairly limited role in the immune system, recognizing and eliminating pathogens. Now, however, complement proteins are known to have a much broader role in immunity, and dysregulation of the complement system has been shown to affect the pathogenesis and clinical picture of several autoimmune diseases. This supplement discusses the role of complement-dependent cytotoxicity in the pathophysiology of neuromyelitis optica spectrum disorders.
Click here to read the supplement
US/UNB-NMO/17/0002c
The complement system was once thought to have a fairly limited role in the immune system, recognizing and eliminating pathogens. Now, however, complement proteins are known to have a much broader role in immunity, and dysregulation of the complement system has been shown to affect the pathogenesis and clinical picture of several autoimmune diseases. This supplement discusses the role of complement-dependent cytotoxicity in the pathophysiology of neuromyelitis optica spectrum disorders.
Click here to read the supplement
US/UNB-NMO/17/0002c
Critical Role of Complement-Dependent Cytotoxicity
Critical Role of Complement-Dependent Cytotoxicity
The Benefits and Risks of Oral Antiplatelet Therapy in Patients With Acute Coronary Syndrome
The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today.
The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today.
The Cardiovascular Insights for Primary Care Physicians eNewsletter Series summarizes key information and data on common cardiovascular issues facing primary care physicians today.
